Aspasia Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.00 M
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.95 Cr
- Revenue Growth %
- Profit Growth -98504.90%
- Ebitda 7526.35%
- Net Worth -82.93%
- Total Assets 466.41%
About Aspasia Lifescience
Aspasia Lifescience Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 November 2021 (Three years and three months 14 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹3.95 Cr.
Girjesh Kumar and Vinod Singh serve as directors at the Company.
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230UR2021PTC013186
- Company No.
013186
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Aspasia Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girjesh Kumar  | Director | 10-Nov-2021 | Current |
| Vinod Singh | Director | 10-Nov-2021 | Current |
Financial Performance of Aspasia Lifescience.
Aspasia Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 98504.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 82.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspasia Lifescience?
Unlock access to Aspasia Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aspasia Healthcare Private LimitedGirjesh Kumar is a mutual person
- Ablin Pharma Private Limited
Girjesh Kumar is a mutual person
Charges (Loans)
₹3.95 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2022 | Canara Bank | ₹3.95 Cr | Open |
How Many Employees Work at Aspasia Lifescience?
Aspasia Lifescience has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspasia Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspasia Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.